Investment Advice of Dialysis Companies: Whats the Trend of the Industry?

Abstract

The global dialysis market is continuing expanding in the recent years and dialysis industry has expected investment prospects. This study presents a comprehensive investment analysis framework comparing four top companies in the kidney care and dialysis service industry. This article aims help investor choose the most suitable company among them with the highest investment value to invest in. The study uses official financial data from Nasdaq from 2023 and forecast data from estimates of 2024 of 4 dialysis companies on the waiting list. By analyzing and comparing the financial statements of four companies, the asset investment potential and growth rate of the four companies were determined. Results demonstrate that the company DaVita rank as the most appealing investment option out of four companies, followed by Medtronic, Baxter and Fresenius. Based on financial statements, DaVita is attractive with highest expected growth rates in EPS and gross revenue, PEG ratio, and relatively high annual and quarterly gross margin.